Related Experiment Video
Updated: Jun 30, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability
Tiefeng Jin1, Lingling Ding1, Jinming Chen2
1Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Chromosome instability drives anaplastic thyroid cancer (ATC). The BUB1 kinase promotes ATC aggressiveness by inducing chromosome instability via KIF14 phosphorylation, making BUB1 a potential therapeutic target for ATC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chromosome instability (CIN) is a known driver of anaplastic thyroid cancer (ATC) progression.
- The role of BUB1 mitotic checkpoint serine/threonine kinase (BUB1) in ATC pathogenesis is not well understood.
Purpose of the Study:
- To investigate the role of BUB1 in ATC development and progression.
- To elucidate the underlying molecular mechanisms by which BUB1 influences ATC aggressiveness.
Main Methods:
- Analysis of BUB1 expression in ATC samples and correlation with patient survival.
- In vitro studies involving BUB1 knockdown and overexpression in ATC and papillary thyroid cancer cells.
- In vivo studies using nude mice xenografts and zebrafish models to assess tumor growth and metastasis.
- Investigation of BUB1's interaction with KIF14 and its phosphorylation at Serine 1292.
Main Results:
- BUB1 is significantly upregulated in ATC and associated with poorer progression-free survival.
- BUB1 inhibition reduces ATC cell viability, invasion, migration, and induces cell cycle arrest.
- BUB1 knockdown suppresses tumor growth and metastasis in vivo.
- BUB1 induces CIN in ATC cells by phosphorylating KIF14 at Ser1292, promoting cancer aggressiveness.
Conclusions:
- The BUB1/KIF14 complex is a key driver of ATC aggressiveness through the induction of CIN.
- Targeting BUB1, potentially with inhibitors like BAY-1816032, shows therapeutic potential for ATC.
More Related Videos
Related Concept Videos
Anaphase Promoting Complex
Abnormal Proliferation
Inhibition of Cdk Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Microtubule Instability
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

